Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ELTP - Elite Pharmaceuticals seeks FDA approval for generic antimetabolite drug


ELTP - Elite Pharmaceuticals seeks FDA approval for generic antimetabolite drug

2023-04-20 06:47:53 ET

  • Elite Pharmaceuticals ( OTCQB:ELTP ) filed an application to the U.S. Food and Drug Administration (FDA) seeking approval for an undisclosed generic drug in a class of medicines called antimetabolites.
  • The company said that IQVIA reported annual sales for the year ending December 2022 of $42M for the generic market of the product.

For further details see:

Elite Pharmaceuticals seeks FDA approval for generic antimetabolite drug
Stock Information

Company Name: Elite Pharmaceuticals Inc.
Stock Symbol: ELTP
Market: OTC
Website: elitepharma.com

Menu

ELTP ELTP Quote ELTP Short ELTP News ELTP Articles ELTP Message Board
Get ELTP Alerts

News, Short Squeeze, Breakout and More Instantly...